Machine Learning Remidio’s Revolutionary AI on a Smartphone for Referable Diabetic Retinopathy (Dr) Receives EU Mdr… PRNewswire Feb 24, 2023 Remidio has received CE mark approval for its Medios AI, to detect Referable DR. This approval closely follows the nod the AI received from …
Machine Learning Remidio Medios AI shows Significant Promise in last-mile Screening for Referable Glaucoma AIT News Desk Jul 8, 2022 Glaucoma, one of the world's leading causes of irreversible blindness, is expected to affect an estimated 120 million by 2040, globally. Treatment…